Formulary Decisions
Search for the outcome of decisions made by the Formulary Committee
Conjugated oestrogens + Medroxyprogesterone
Premique Low Dose
Routinely available
SMC (130/04)
29/03/2023
Indication
Hormone replacement therapy for oestrogen deficiency symptoms in postmenopausal women with an intact uterus
Therapeutic Area
Endocrine system
Status Description
Routinely available in line with national guidance
Formulation
0.3mg/1.5mg modified-release tablets
Comments
-